Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol
article
OA: green
CC0
⤵ 4 in-corpus citations
AI-generated summary
This study prospectively measured 24-hour blood pressure and heart rate in women using combined oral contraceptives containing estradiol.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive 2011
- Effect of four oral contraceptives on hemostatic parameters 2004
- Review of clinical experience with estradiol in combined oral contraceptives 2009
Cited by (4)
- Metabolic impact of combined hormonal contraceptives containing estradiol 2016
- Needs, expectations and doubt users of hormonal contraceptives 2020
- Real clinical practice and contraception for young women with children 2021
- Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives? 2018
References (31)
- Effect of four oral contraceptives on hemostatic parameters via openalex
- Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive via openalex
- Review of clinical experience with estradiol in combined oral contraceptives via openalex
- doi:10.1136/bmj.1.5907.533 via openalex
- doi:10.1016/s0015-0282(16)57909-6 via openalex
- doi:10.1111/j.1471-0528.1984.tb04747.x via openalex
- doi:10.1016/j.steroids.2011.02.002 via openalex
- doi:10.3109/07853890108998748 via openalex
- doi:10.1210/jc.83.4.1292 via openalex
- doi:10.1093/eurheartj/ehm236 via openalex
- W6654890293 via openalex
- W6686362561 via openalex
- W6821101079 via openalex
- doi:10.1016/j.contraception.2013.04.003 via openalex
- doi:10.1016/0010-7824(95)00097-t via openalex
- doi:10.1016/j.jacc.2007.04.079 via openalex
- doi:10.1016/j.fertnstert.2008.03.082 via openalex
- doi:10.1210/jcem.83.4.4710 via openalex
- doi:10.3109/09513590.2014.922947 via openalex
- doi:10.5402/2011/924343 via openalex
- doi:10.1001/jama.1977.03270500051024 via openalex
- doi:10.1016/0010-7824(95)00153-2 via openalex
- doi:10.1097/00004872-199816030-00013 via openalex
- doi:10.1152/ajpheart.1999.276.4.h1355 via openalex
- doi:10.3109/13625187.2011.604450 via openalex
- doi:10.1016/j.jacc.2010.09.014 via openalex
- doi:10.1097/hjh.0b013e32835b8d8b via openalex
- doi:10.1016/j.contraception.2012.12.002 via openalex
- doi:10.1001/jama.1991.03460240051027 via openalex
- doi:10.3109/07420529609012653 via openalex
- doi:10.1056/nejm199506293322607 via openalex
Cited by (4)
- Real clinical practice and contraception for young women with children 2021
- Needs, expectations and doubt users of hormonal contraceptives 2020
- Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives? 2018
- Metabolic impact of combined hormonal contraceptives containing estradiol 2016
Source provenance
- openalex
- last seen: 2026-05-11T06:25:09.493344+00:00
License: CC0
· commercial use OK